ADGRL1-IN-1
ADGRL1-IN-1 is a ADGRL1 inhibitor. ADGRL1-IN-1 activates the GSK3β-STAT1 signaling axis. ADGRL1-IN-1 induces anti-tumor immunity in a CT26 colorectal cancer mouse model. ADGRL1-IN-1 can be used in studies related to colorectal cancer.
For research use only. We do not sell to patients.
- CAS No.: 693829-95-7
- Formula: C16H9BrF3NO
- Molecular Weight:368.15
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
GSK-3β |
STAT1 |
ADGRL1-IN-1 (Compound 2) (15 mM) binds directly to ADGRL1 in CT26 cells, as evidenced by its ability to protect the receptor from protease degradation at a concentration of 15 mM[1].
ADGRL1-IN-1 activates the GSK3β-STAT1 axis in CT26 cells and induces BMDC activation via factors secreted by CT26 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 693829-95-7
-
Molecular Weight 368.15
-
Formula C16H9BrF3NO
-
SMILES
FC(C1=CN=C(OC2=CC=C3C=CC=CC3=C2Br)C=C1)(F)F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)